Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

Lattice lightsheet

The understanding of the numerous and complex processes that underpin human health and disease are dependent on new and advanced imaging techniques that enable the function and behaviour of cells to be observed. Historically, biomedical researchers have made use of a variety of microscopy instruments to try and answer their research questions in different ways. But as many come with limitations in their technical sensitivity, are invasive methods, or are unable to image live cells with spatial context over time, the KIR and IDRM have added a new state-of-the-art microscope to its arsenal of optical imaging technology. 

“The ZEISS Lattice Lightsheet 7 gives us unprecedented resolution to observe biology and its physiological states in four dimensions i.e., three dimensions of space, and over time,” said Professor Marco Fritzsche, Associate Professor and Rosalind Franklin Kennedy Trust Research Fellow. “And it does so in a minimally invasive way. Typically, when you do fluorescence microscopy the cells are damaged or eliminated by the light and that makes it particularly difficult to image in three dimensions. This new innovation from ZEISS overcomes this issue so we can watch biology live as it unfolds over time.”

As the first serial production ZEISS Lattice Lightsheet 7 to be installed globally, it gives the IDRM and KIR the capability to view cells and their cell-to-cell processes in their tissue micro-environment and within whole organism in vivo in space and time. As an example, Professor Michael Dustin, Scientific Director at the KIR, is using the technology to image the formation of an immunological synapse, which will help advance the translation to treatment of human diseases including auto-immune conditions and cancer. Professor Paul Riley, Director of the IDRM, together with Professors Shankar Srinivas and Professor Georg Hollaender will apply the ZEISS Lattice Lightsheet 7 to study the cellular dynamics of embryos during development of their cardiovascular and immune systems, allowing unprecedented insights under physiological conditions.

The strategic partnership between the IDRM and KIR and ZEISS to develop the Lattice Lightsheet 7 technology is unique in Oxford and beyond. “Together we are committed to advancing optical imaging technology and advanced image analysis to improve research in the field of biomedical sciences.” We expect that technologies such as the ZEISS Lattice Lightsheet 7 will replace conventional imaging technologies in the future,” said Marco.

“ZEISS has a long history of close collaboration with cutting edge scientists. This strategic partnership clearly demonstrates that ZEISS still lives the philosophy laid down by its founding partners 175 years ago. This is a very proud moment for everyone involved” said Dr. Ben Ewins, ZEISS account manager for Oxford University.

The strategic collaboration between Oxford and ZEISS at KIR will yield exciting opportunities for innovation in the field imaging.  We [ZEISS] are particularly excited about starting work on some important topics such as software artificial intelligence and large scale data management.  This is a great opportunity for two historic institutions to work together on some extremely relevant and cutting edge topics.

Similar stories

Furniss Group paper wins journal award

Editors at the Journal of Hand Surgery have recognised the Furniss Group with an award for the best paper published in the Journal in 2022. The Editor’s Award recognises research with scientific importance, outstanding study stringency, and a high academic standard.

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.